CTI CAPITAL

CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.
CTI CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
1987-01-01
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS Google Maps API GoDaddy
Current Advisors List
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-01-18 | Wattio | CTI Capital investment in Venture Round - Wattio | 170 K EUR |
2014-07-14 | Xagenic | CTI Capital investment in Series B - Xagenic | 25.5 M USD |
2012-01-30 | Xagenic | CTI Capital investment in Series A - Xagenic | 10 M USD |
2011-09-22 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 8.1 M USD |
2009-08-10 | Enobia Pharma | CTI Capital investment in Series C - Enobia Pharma | 50 M USD |
2009-06-29 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 3.2 M USD |
2000-03-31 | BeXcom | CTI Capital investment in Venture Round - BeXcom | 75 M USD |